UPDATE 1-Teva Pharm sees 2015 revenue lower than forecast
December 11, 2014 at 08:16 AM EST
TEL AVIV, Dec 11 (Reuters) - Teva Pharmaceutical Industries forecast 2015 revenue below analysts' expectations, due to adverse foreign exchange moves and generic competition for its best-selling multiple sclerosis treatment Copaxone.
